These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

529 related articles for article (PubMed ID: 26134627)

  • 1. Plastin 3 Expression Does Not Modify Spinal Muscular Atrophy Severity in the ∆7 SMA Mouse.
    McGovern VL; Massoni-Laporte A; Wang X; Le TT; Le HT; Beattie CE; Rich MM; Burghes AH
    PLoS One; 2015; 10(7):e0132364. PubMed ID: 26134627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Power of Human Protective Modifiers: PLS3 and CORO1C Unravel Impaired Endocytosis in Spinal Muscular Atrophy and Rescue SMA Phenotype.
    Hosseinibarkooie S; Peters M; Torres-Benito L; Rastetter RH; Hupperich K; Hoffmann A; Mendoza-Ferreira N; Kaczmarek A; Janzen E; Milbradt J; Lamkemeyer T; Rigo F; Bennett CF; Guschlbauer C; Büschges A; Hammerschmidt M; Riessland M; Kye MJ; Clemen CS; Wirth B
    Am J Hum Genet; 2016 Sep; 99(3):647-665. PubMed ID: 27499521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CHP1 reduction ameliorates spinal muscular atrophy pathology by restoring calcineurin activity and endocytosis.
    Janzen E; Mendoza-Ferreira N; Hosseinibarkooie S; Schneider S; Hupperich K; Tschanz T; Grysko V; Riessland M; Hammerschmidt M; Rigo F; Bennett CF; Kye MJ; Torres-Benito L; Wirth B
    Brain; 2018 Aug; 141(8):2343-2361. PubMed ID: 29961886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of potential effects of Plastin 3 overexpression and low-dose SMN-antisense oligonucleotides on putative biomarkers in spinal muscular atrophy mice.
    Strathmann EA; Peters M; Hosseinibarkooie S; Rigo FW; Bennett CF; Zaworski PG; Chen KS; Nothnagel M; Wirth B
    PLoS One; 2018; 13(9):e0203398. PubMed ID: 30188931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurocalcin Delta Suppression Protects against Spinal Muscular Atrophy in Humans and across Species by Restoring Impaired Endocytosis.
    Riessland M; Kaczmarek A; Schneider S; Swoboda KJ; Löhr H; Bradler C; Grysko V; Dimitriadi M; Hosseinibarkooie S; Torres-Benito L; Peters M; Upadhyay A; Biglari N; Kröber S; Hölker I; Garbes L; Gilissen C; Hoischen A; Nürnberg G; Nürnberg P; Walter M; Rigo F; Bennett CF; Kye MJ; Hart AC; Hammerschmidt M; Kloppenburg P; Wirth B
    Am J Hum Genet; 2017 Feb; 100(2):297-315. PubMed ID: 28132687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plastin-3 extends survival and reduces severity in mouse models of spinal muscular atrophy.
    Kaifer KA; Villalón E; Osman EY; Glascock JJ; Arnold LL; Cornelison DDW; Lorson CL
    JCI Insight; 2017 Mar; 2(5):e89970. PubMed ID: 28289706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plastin 3 ameliorates spinal muscular atrophy via delayed axon pruning and improves neuromuscular junction functionality.
    Ackermann B; Kröber S; Torres-Benito L; Borgmann A; Peters M; Hosseini Barkooie SM; Tejero R; Jakubik M; Schreml J; Milbradt J; Wunderlich TF; Riessland M; Tabares L; Wirth B
    Hum Mol Genet; 2013 Apr; 22(7):1328-47. PubMed ID: 23263861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calcium binding is essential for plastin 3 function in Smn-deficient motoneurons.
    Lyon AN; Pineda RH; Hao le T; Kudryashova E; Kudryashov DS; Beattie CE
    Hum Mol Genet; 2014 Apr; 23(8):1990-2004. PubMed ID: 24271012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plastin 3 expression in discordant spinal muscular atrophy (SMA) siblings.
    Bernal S; Also-Rallo E; Martínez-Hernández R; Alías L; Rodríguez-Alvarez FJ; Millán JM; Hernández-Chico C; Baiget M; Tizzano EF
    Neuromuscul Disord; 2011 Jun; 21(6):413-9. PubMed ID: 21546251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plastin 3 is upregulated in iPSC-derived motoneurons from asymptomatic SMN1-deleted individuals.
    Heesen L; Peitz M; Torres-Benito L; Hölker I; Hupperich K; Dobrindt K; Jungverdorben J; Ritzenhofen S; Weykopf B; Eckert D; Hosseini-Barkooie SM; Storbeck M; Fusaki N; Lonigro R; Heller R; Kye MJ; Brüstle O; Wirth B
    Cell Mol Life Sci; 2016 May; 73(10):2089-104. PubMed ID: 26573968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ZPR1 prevents R-loop accumulation, upregulates SMN2 expression and rescues spinal muscular atrophy.
    Kannan A; Jiang X; He L; Ahmad S; Gangwani L
    Brain; 2020 Jan; 143(1):69-93. PubMed ID: 31828288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcript levels of plastin 3 and neuritin 1 modifier genes in spinal muscular atrophy siblings.
    Yener İH; Topaloglu H; Erdem-Özdamar S; Dayangac-Erden D
    Pediatr Int; 2017 Jan; 59(1):53-56. PubMed ID: 27279027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SMN deficiency alters Nrxn2 expression and splicing in zebrafish and mouse models of spinal muscular atrophy.
    See K; Yadav P; Giegerich M; Cheong PS; Graf M; Vyas H; Lee SG; Mathavan S; Fischer U; Sendtner M; Winkler C
    Hum Mol Genet; 2014 Apr; 23(7):1754-70. PubMed ID: 24218366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and characterization of an SMN2-based intermediate mouse model of Spinal Muscular Atrophy.
    Cobb MS; Rose FF; Rindt H; Glascock JJ; Shababi M; Miller MR; Osman EY; Yen PF; Garcia ML; Martin BR; Wetz MJ; Mazzasette C; Feng Z; Ko CP; Lorson CL
    Hum Mol Genet; 2013 May; 22(9):1843-55. PubMed ID: 23390132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survival motor neuron affects plastin 3 protein levels leading to motor defects.
    Hao le T; Wolman M; Granato M; Beattie CE
    J Neurosci; 2012 Apr; 32(15):5074-84. PubMed ID: 22496553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peripheral SMN restoration is essential for long-term rescue of a severe spinal muscular atrophy mouse model.
    Hua Y; Sahashi K; Rigo F; Hung G; Horev G; Bennett CF; Krainer AR
    Nature; 2011 Oct; 478(7367):123-6. PubMed ID: 21979052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 5-(N-ethyl-N-isopropyl)-amiloride enhances SMN2 exon 7 inclusion and protein expression in spinal muscular atrophy cells.
    Yuo CY; Lin HH; Chang YS; Yang WK; Chang JG
    Ann Neurol; 2008 Jan; 63(1):26-34. PubMed ID: 17924536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complete sequencing of the SMN2 gene in SMA patients detects SMN gene deletion junctions and variants in SMN2 that modify the SMA phenotype.
    Ruhno C; McGovern VL; Avenarius MR; Snyder PJ; Prior TW; Nery FC; Muhtaseb A; Roggenbuck JS; Kissel JT; Sansone VA; Siranosian JJ; Johnstone AJ; Nwe PH; Zhang RZ; Swoboda KJ; Burghes AHM
    Hum Genet; 2019 Mar; 138(3):241-256. PubMed ID: 30788592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SAHA ameliorates the SMA phenotype in two mouse models for spinal muscular atrophy.
    Riessland M; Ackermann B; Förster A; Jakubik M; Hauke J; Garbes L; Fritzsche I; Mende Y; Blumcke I; Hahnen E; Wirth B
    Hum Mol Genet; 2010 Apr; 19(8):1492-506. PubMed ID: 20097677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combinatorial ASO-mediated therapy with low dose SMN and the protective modifier Chp1 is not sufficient to ameliorate SMA pathology hallmarks.
    Muinos-Bühl A; Rombo R; Janzen E; Ling KK; Hupperich K; Rigo F; Bennett CF; Wirth B
    Neurobiol Dis; 2022 Sep; 171():105795. PubMed ID: 35724821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.